Home / Inspections / 1321482

FDA Inspection 1321482 — Lilly del Caribe, Inc.

Lilly del Caribe, Inc. — FEI 3004525072

The FDA completed an inspection of Lilly del Caribe, Inc. on May 12, 2026 in Carolina, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 12, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carolina, PR (United States)

Facility

Other inspections at this facility

  • 1198613 (VAI Fri Feb 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1069980 (NAI Thu Sep 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 974723 (VAI Wed Jun 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 868382 (NAI Fri Feb 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 776200 (VAI Wed Apr 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources